Schistosoma mansoni: Melatonin enhances efficacy of cercarial and soluble worm antigens in the induction of protective immunity against infection in the hamster
Based on the beneficial influence of melatonin administration on the course of schistosomiasis and on its possible action on the immune system, we aimed in this study to establish an immunization program using Schistosoma mansoni adult worm antigen (SWAP) and cercarial antigen (CAP) alone or concurr...
Gespeichert in:
Veröffentlicht in: | Experimental parasitology 2008-06, Vol.119 (2), p.291-295 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 295 |
---|---|
container_issue | 2 |
container_start_page | 291 |
container_title | Experimental parasitology |
container_volume | 119 |
creator | Soliman, Maha F.M. El Shenawy, Nahla S. El Arabi, Shimaa E. |
description | Based on the beneficial influence of melatonin administration on the course of schistosomiasis and on its possible action on the immune system, we aimed in this study to establish an immunization program using
Schistosoma mansoni adult worm antigen (SWAP) and cercarial antigen (CAP) alone or concurrently with melatonin treatment, for 30 successive days, in an attempt to enhance their efficacy against the infection in hamsters. Results showed that the worm reduction percentages were 53.8%, 67.01%, 56.4% and 99.3% for CAP, CAP
+
melatonin, SWAP, SWAP
+
melatonin, respectively, indicating that melatonin enhanced efficacy of SWAP but only produced a slight increase in efficacy of CAP. Highly significant reductions in egg load in the liver and alteration in the oogram pattern with a high percentage of immature eggs and few dead eggs were recorded in the groups that received melatonin treatment suggesting a possible role for melatonin in the regulation of egg production and development. On the other hand, melatonin clearly improved the oxidative status in the immunized groups. No antibody (Ab) response was recorded in the groups immunized with SWAP
+
melatonin while low Ab level was seen in the other melatonin-treated group. In addition to the antioxidant properties of melatonin, our results suggested that the early and continuous melatonin administration may result in immunomodulatory actions which in turn enhanced the efficacy of SWAP and CAP in different ways. This indicates the importance of further investigation of the mechanisms of melatonin action and the possible application in a vaccination program. |
doi_str_mv | 10.1016/j.exppara.2008.01.013 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69175712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014489408000362</els_id><sourcerecordid>69175712</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-bf42c526341f7abac9cd30255dc2b0881a1ff8ad355e01e7503c8bbd1677934f3</originalsourceid><addsrcrecordid>eNqFkduKFDEQhhtR3NnVR1Byo3c95tgHb0QWXYUVL9TrUJ2u7GToTsYkvTpv46OaYRq9XCioA9-fFPVX1QtGt4yy5s1-i78PB4iw5ZR2W8pKiEfVhtGe1lzK_nG1oZTJWna9vKguU9rTAjIun1YXrBOCtUJsqj_fzM6lHFKYgczgU_DuLfmCE-RSeYJ-B95gImitM2COJFhiMBqIDiYCfiQpTMswIfkV4lwG2d2hT6Ro8w5LGheTXfAn3SGGjKW7L_N5XrzLRwJ34HzKBbR4BlflDuaUMT6rnliYEj5f81X14-OH79ef6tuvN5-v39_WRnKZ68FKbhRvhGS2hQFMb0ZBuVKj4QPtOgbM2g5GoRRShq2iwnTDMLKmbXshrbiqXp_fLUv-XDBlPbtkcJrAY1iSbnrWqpbxB0FOW9ZS1RRQnUETQ0oRrT5EN0M8akb1yUO916uH-uShpqyEKLqX6wfLMOP4X7WaVoBXKwDJwGRjccilfxynQjGhusK9O3NY7nbvMOpkHBY3RxfLrfUY3AOr_AXQnMDo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20717056</pqid></control><display><type>article</type><title>Schistosoma mansoni: Melatonin enhances efficacy of cercarial and soluble worm antigens in the induction of protective immunity against infection in the hamster</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Soliman, Maha F.M. ; El Shenawy, Nahla S. ; El Arabi, Shimaa E.</creator><creatorcontrib>Soliman, Maha F.M. ; El Shenawy, Nahla S. ; El Arabi, Shimaa E.</creatorcontrib><description>Based on the beneficial influence of melatonin administration on the course of schistosomiasis and on its possible action on the immune system, we aimed in this study to establish an immunization program using
Schistosoma mansoni adult worm antigen (SWAP) and cercarial antigen (CAP) alone or concurrently with melatonin treatment, for 30 successive days, in an attempt to enhance their efficacy against the infection in hamsters. Results showed that the worm reduction percentages were 53.8%, 67.01%, 56.4% and 99.3% for CAP, CAP
+
melatonin, SWAP, SWAP
+
melatonin, respectively, indicating that melatonin enhanced efficacy of SWAP but only produced a slight increase in efficacy of CAP. Highly significant reductions in egg load in the liver and alteration in the oogram pattern with a high percentage of immature eggs and few dead eggs were recorded in the groups that received melatonin treatment suggesting a possible role for melatonin in the regulation of egg production and development. On the other hand, melatonin clearly improved the oxidative status in the immunized groups. No antibody (Ab) response was recorded in the groups immunized with SWAP
+
melatonin while low Ab level was seen in the other melatonin-treated group. In addition to the antioxidant properties of melatonin, our results suggested that the early and continuous melatonin administration may result in immunomodulatory actions which in turn enhanced the efficacy of SWAP and CAP in different ways. This indicates the importance of further investigation of the mechanisms of melatonin action and the possible application in a vaccination program.</description><identifier>ISSN: 0014-4894</identifier><identifier>EISSN: 1090-2449</identifier><identifier>DOI: 10.1016/j.exppara.2008.01.013</identifier><identifier>PMID: 18331733</identifier><identifier>CODEN: EXPAAA</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Adjuvants, Immunologic - administration & dosage ; Adjuvants, Immunologic - pharmacology ; Adjuvants, Immunologic - therapeutic use ; Animals ; Antigens ; Antigens, Helminth - drug effects ; Antigens, Helminth - immunology ; Antioxidants - administration & dosage ; Antioxidants - pharmacology ; Antioxidants - therapeutic use ; Biological and medical sciences ; Cricetinae ; Fundamental and applied biological sciences. Psychology ; Immunization ; Immunization - methods ; Immunization - standards ; Life cycle. Host-agent relationship. Pathogenesis ; Male ; Melatonin ; Melatonin - administration & dosage ; Melatonin - pharmacology ; Melatonin - therapeutic use ; Mesocricetus ; Protozoa ; Schistosoma mansoni ; Schistosoma mansoni - immunology ; Schistosomiasis ; Schistosomiasis mansoni - prevention & control</subject><ispartof>Experimental parasitology, 2008-06, Vol.119 (2), p.291-295</ispartof><rights>2008 Elsevier Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-bf42c526341f7abac9cd30255dc2b0881a1ff8ad355e01e7503c8bbd1677934f3</citedby><cites>FETCH-LOGICAL-c424t-bf42c526341f7abac9cd30255dc2b0881a1ff8ad355e01e7503c8bbd1677934f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014489408000362$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20351358$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18331733$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soliman, Maha F.M.</creatorcontrib><creatorcontrib>El Shenawy, Nahla S.</creatorcontrib><creatorcontrib>El Arabi, Shimaa E.</creatorcontrib><title>Schistosoma mansoni: Melatonin enhances efficacy of cercarial and soluble worm antigens in the induction of protective immunity against infection in the hamster</title><title>Experimental parasitology</title><addtitle>Exp Parasitol</addtitle><description>Based on the beneficial influence of melatonin administration on the course of schistosomiasis and on its possible action on the immune system, we aimed in this study to establish an immunization program using
Schistosoma mansoni adult worm antigen (SWAP) and cercarial antigen (CAP) alone or concurrently with melatonin treatment, for 30 successive days, in an attempt to enhance their efficacy against the infection in hamsters. Results showed that the worm reduction percentages were 53.8%, 67.01%, 56.4% and 99.3% for CAP, CAP
+
melatonin, SWAP, SWAP
+
melatonin, respectively, indicating that melatonin enhanced efficacy of SWAP but only produced a slight increase in efficacy of CAP. Highly significant reductions in egg load in the liver and alteration in the oogram pattern with a high percentage of immature eggs and few dead eggs were recorded in the groups that received melatonin treatment suggesting a possible role for melatonin in the regulation of egg production and development. On the other hand, melatonin clearly improved the oxidative status in the immunized groups. No antibody (Ab) response was recorded in the groups immunized with SWAP
+
melatonin while low Ab level was seen in the other melatonin-treated group. In addition to the antioxidant properties of melatonin, our results suggested that the early and continuous melatonin administration may result in immunomodulatory actions which in turn enhanced the efficacy of SWAP and CAP in different ways. This indicates the importance of further investigation of the mechanisms of melatonin action and the possible application in a vaccination program.</description><subject>Adjuvants, Immunologic - administration & dosage</subject><subject>Adjuvants, Immunologic - pharmacology</subject><subject>Adjuvants, Immunologic - therapeutic use</subject><subject>Animals</subject><subject>Antigens</subject><subject>Antigens, Helminth - drug effects</subject><subject>Antigens, Helminth - immunology</subject><subject>Antioxidants - administration & dosage</subject><subject>Antioxidants - pharmacology</subject><subject>Antioxidants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cricetinae</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Immunization</subject><subject>Immunization - methods</subject><subject>Immunization - standards</subject><subject>Life cycle. Host-agent relationship. Pathogenesis</subject><subject>Male</subject><subject>Melatonin</subject><subject>Melatonin - administration & dosage</subject><subject>Melatonin - pharmacology</subject><subject>Melatonin - therapeutic use</subject><subject>Mesocricetus</subject><subject>Protozoa</subject><subject>Schistosoma mansoni</subject><subject>Schistosoma mansoni - immunology</subject><subject>Schistosomiasis</subject><subject>Schistosomiasis mansoni - prevention & control</subject><issn>0014-4894</issn><issn>1090-2449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkduKFDEQhhtR3NnVR1Byo3c95tgHb0QWXYUVL9TrUJ2u7GToTsYkvTpv46OaYRq9XCioA9-fFPVX1QtGt4yy5s1-i78PB4iw5ZR2W8pKiEfVhtGe1lzK_nG1oZTJWna9vKguU9rTAjIun1YXrBOCtUJsqj_fzM6lHFKYgczgU_DuLfmCE-RSeYJ-B95gImitM2COJFhiMBqIDiYCfiQpTMswIfkV4lwG2d2hT6Ro8w5LGheTXfAn3SGGjKW7L_N5XrzLRwJ34HzKBbR4BlflDuaUMT6rnliYEj5f81X14-OH79ef6tuvN5-v39_WRnKZ68FKbhRvhGS2hQFMb0ZBuVKj4QPtOgbM2g5GoRRShq2iwnTDMLKmbXshrbiqXp_fLUv-XDBlPbtkcJrAY1iSbnrWqpbxB0FOW9ZS1RRQnUETQ0oRrT5EN0M8akb1yUO916uH-uShpqyEKLqX6wfLMOP4X7WaVoBXKwDJwGRjccilfxynQjGhusK9O3NY7nbvMOpkHBY3RxfLrfUY3AOr_AXQnMDo</recordid><startdate>20080601</startdate><enddate>20080601</enddate><creator>Soliman, Maha F.M.</creator><creator>El Shenawy, Nahla S.</creator><creator>El Arabi, Shimaa E.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20080601</creationdate><title>Schistosoma mansoni: Melatonin enhances efficacy of cercarial and soluble worm antigens in the induction of protective immunity against infection in the hamster</title><author>Soliman, Maha F.M. ; El Shenawy, Nahla S. ; El Arabi, Shimaa E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-bf42c526341f7abac9cd30255dc2b0881a1ff8ad355e01e7503c8bbd1677934f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adjuvants, Immunologic - administration & dosage</topic><topic>Adjuvants, Immunologic - pharmacology</topic><topic>Adjuvants, Immunologic - therapeutic use</topic><topic>Animals</topic><topic>Antigens</topic><topic>Antigens, Helminth - drug effects</topic><topic>Antigens, Helminth - immunology</topic><topic>Antioxidants - administration & dosage</topic><topic>Antioxidants - pharmacology</topic><topic>Antioxidants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cricetinae</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Immunization</topic><topic>Immunization - methods</topic><topic>Immunization - standards</topic><topic>Life cycle. Host-agent relationship. Pathogenesis</topic><topic>Male</topic><topic>Melatonin</topic><topic>Melatonin - administration & dosage</topic><topic>Melatonin - pharmacology</topic><topic>Melatonin - therapeutic use</topic><topic>Mesocricetus</topic><topic>Protozoa</topic><topic>Schistosoma mansoni</topic><topic>Schistosoma mansoni - immunology</topic><topic>Schistosomiasis</topic><topic>Schistosomiasis mansoni - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soliman, Maha F.M.</creatorcontrib><creatorcontrib>El Shenawy, Nahla S.</creatorcontrib><creatorcontrib>El Arabi, Shimaa E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soliman, Maha F.M.</au><au>El Shenawy, Nahla S.</au><au>El Arabi, Shimaa E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Schistosoma mansoni: Melatonin enhances efficacy of cercarial and soluble worm antigens in the induction of protective immunity against infection in the hamster</atitle><jtitle>Experimental parasitology</jtitle><addtitle>Exp Parasitol</addtitle><date>2008-06-01</date><risdate>2008</risdate><volume>119</volume><issue>2</issue><spage>291</spage><epage>295</epage><pages>291-295</pages><issn>0014-4894</issn><eissn>1090-2449</eissn><coden>EXPAAA</coden><abstract>Based on the beneficial influence of melatonin administration on the course of schistosomiasis and on its possible action on the immune system, we aimed in this study to establish an immunization program using
Schistosoma mansoni adult worm antigen (SWAP) and cercarial antigen (CAP) alone or concurrently with melatonin treatment, for 30 successive days, in an attempt to enhance their efficacy against the infection in hamsters. Results showed that the worm reduction percentages were 53.8%, 67.01%, 56.4% and 99.3% for CAP, CAP
+
melatonin, SWAP, SWAP
+
melatonin, respectively, indicating that melatonin enhanced efficacy of SWAP but only produced a slight increase in efficacy of CAP. Highly significant reductions in egg load in the liver and alteration in the oogram pattern with a high percentage of immature eggs and few dead eggs were recorded in the groups that received melatonin treatment suggesting a possible role for melatonin in the regulation of egg production and development. On the other hand, melatonin clearly improved the oxidative status in the immunized groups. No antibody (Ab) response was recorded in the groups immunized with SWAP
+
melatonin while low Ab level was seen in the other melatonin-treated group. In addition to the antioxidant properties of melatonin, our results suggested that the early and continuous melatonin administration may result in immunomodulatory actions which in turn enhanced the efficacy of SWAP and CAP in different ways. This indicates the importance of further investigation of the mechanisms of melatonin action and the possible application in a vaccination program.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>18331733</pmid><doi>10.1016/j.exppara.2008.01.013</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4894 |
ispartof | Experimental parasitology, 2008-06, Vol.119 (2), p.291-295 |
issn | 0014-4894 1090-2449 |
language | eng |
recordid | cdi_proquest_miscellaneous_69175712 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adjuvants, Immunologic - administration & dosage Adjuvants, Immunologic - pharmacology Adjuvants, Immunologic - therapeutic use Animals Antigens Antigens, Helminth - drug effects Antigens, Helminth - immunology Antioxidants - administration & dosage Antioxidants - pharmacology Antioxidants - therapeutic use Biological and medical sciences Cricetinae Fundamental and applied biological sciences. Psychology Immunization Immunization - methods Immunization - standards Life cycle. Host-agent relationship. Pathogenesis Male Melatonin Melatonin - administration & dosage Melatonin - pharmacology Melatonin - therapeutic use Mesocricetus Protozoa Schistosoma mansoni Schistosoma mansoni - immunology Schistosomiasis Schistosomiasis mansoni - prevention & control |
title | Schistosoma mansoni: Melatonin enhances efficacy of cercarial and soluble worm antigens in the induction of protective immunity against infection in the hamster |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T13%3A56%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Schistosoma%20mansoni:%20Melatonin%20enhances%20efficacy%20of%20cercarial%20and%20soluble%20worm%20antigens%20in%20the%20induction%20of%20protective%20immunity%20against%20infection%20in%20the%20hamster&rft.jtitle=Experimental%20parasitology&rft.au=Soliman,%20Maha%20F.M.&rft.date=2008-06-01&rft.volume=119&rft.issue=2&rft.spage=291&rft.epage=295&rft.pages=291-295&rft.issn=0014-4894&rft.eissn=1090-2449&rft.coden=EXPAAA&rft_id=info:doi/10.1016/j.exppara.2008.01.013&rft_dat=%3Cproquest_cross%3E69175712%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20717056&rft_id=info:pmid/18331733&rft_els_id=S0014489408000362&rfr_iscdi=true |